Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survival

Ozyerli-Goknar E., Kala EY., Aksu AC., Bulut I., Cingöz A., Nizamuddin S., Biniossek M., Seker-Polat F., Morova T., Aztekin C., Kung SHA., Syed H., Tuncbag N., Gonen M., Philpott M., Cribbs AP., Acilan C., Lack NA., Onder TT., Timmers HTM., Bagci-Onder T.

DOI

10.1101/2022.08.17.504245

Type

Preprint

Publication Date

2022-08-17T00:00:00+00:00

Permalink More information Close